Chemical Structure : NPS-1034
CAS No.: 1221713-92-3
Catalog No.: PC-20334Not For Human Use, Lab Use Only.
NPS-1034 (NPS1034) is a potent, dual MET and AXL inhibitor with IC50 of 48 and 10.3 nM, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $78 | In stock | |
10 mg | $118 | In stock | |
50 mg | $298 | In stock | |
100 mg | $458 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NPS-1034 (NPS1034) is a potent, dual MET and AXL inhibitor with IC50 of 48 and 10.3 nM, respectively.
NPS-1034 also inhibits other kinases, such as FLT3, KIT, and DDR1.
Combined treatment with NPS-1034 and gefitinib overcomes the drug resistance caused by MET gene amplification.
Addition of NPS-1034 to gefitinib overcomes acquired resistance to gefitinib in a xenograft model.
Addition of NPS-1034 to erlotinib overcomes AXL-mediated drug resistance.
NPS-1034 treatment enhances sensitivity to EGFR-TKIs in H820 cells.
NPS-1034 inhibits ROS1 activity and cell proliferation in HCC78 cells.
M.Wt | 551.55 | |
Formula | C31H23F2N5O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-(4-fluorophenyl)-N-[3-fluoro-4-[(3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo-1H-pyrazole-4-carboxamide |
1. Rho JK, et al. Cancer Res. 2014 Jan 1;74(1):253-62.
2. Shin JS, et al. Invest New Drugs. 2014 Jun;32(3):389-99.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright